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Activation of the main DNA interstrand crosslink
repair pathway in higher eukaryotes requires mono-
ubiquitination of FANCI and FANCD2 by FANCL,
the E3 ligase subunit of the Fanconi anemia core
complex. FANCI and FANCD2 form a stable complex;
however, themolecular basis of their ubiquitination is
ill defined. FANCD2 mono-ubiquitination by FANCL
is stimulated by the presence of the FANCB and
FAAP100 core complex components, through an
unknown mechanism. How FANCI mono-ubiquitina-
tion is achieved remains unclear. Here, we use struc-
tural electron microscopy, combined with crosslink-
coupled mass spectrometry, to find that FANCB,
FANCL, and FAAP100 form a dimer of trimers, con-
taining two FANCL molecules that are ideally poised
to target both FANCI and FANCD2 for mono-ubiqui-
tination. The FANCC-FANCE-FANCF subunits bridge
between FANCB-FANCL-FAAP100 and the FANCI-
FANCD2 substrate. A transient interaction with
FANCC-FANCE-FANCF alters the FANCI-FANCD2
configuration, stabilizing the dimerization interface.
Our data provide a model to explain how equivalent
mono-ubiquitination of FANCI and FANCD2 occurs.INTRODUCTION
Interstrand crosslinks (ICLs) are toxic DNA lesions that prevent
the separation of the two filaments in the DNA double helix, im-
pairing DNA replication and transcription. The Fanconi anemia
(FA)/BRCA pathway is the major interstrand crosslink repair pro-
cess in higher eukaryotes (Knipscheer et al., 2009; Kottemann
and Smogorzewska, 2013). Activation of this pathway dependsThis is an open access article under the CC BY-Non the specific mono-ubiquitination of the FANCI and FANCD2
proteins by the FA core complex (Ceccaldi et al., 2016; Garcia-
Higuera et al., 2001; Sims et al., 2007; Smogorzewska et al.,
2007; Timmers et al., 2001). Mutations in the FA genes cause a
rare genetic disorder characterized by hypersensitivity to cross-
linking agents, chromosomal instability, and cancer predisposi-
tion (Deans and West, 2011).
Despite the enormous effort of several research groups, a
mechanistic understanding of the activation of the FA ICL repair
pathway is only starting to emerge (Walden and Deans, 2014). A
key player in the recognition of ICLs is the FA anchor complex
(consisting of the FANCM DNA translocase, FAAP24, and two
histone-like factors named MHF1-2), which, in turn, recruits the
FA core complex to the DNA damage site (Ciccia et al., 2007;
Coulthard et al., 2013; Kim et al., 2008; Yan et al., 2010).
The core complex is composed of three distinct protein assem-
blies with non-redundant functions: FANCB-FANCL-FAAP100
(hereinafter called BL100), FANCC-FANCE-FANCF (CEF), and
FANCA-FANCG-FAAP20 (AG20) (Huang et al., 2014; Rajendra
et al., 2014). While the AG20 and CEF play loosely defined ancil-
lary roles (Wang and Smogorzewska, 2015), the BL100 complex
is a three-member ubiquitin ligase, with FANCL as the minimal
unit required for ubiquitination (Huang et al., 2014; Meetei
et al., 2003; Rajendra et al., 2014). FANCL is an E3 ligase contain-
ing a RING domain that is essential for the interaction with the E2
enzyme, UBE2T/FANCT, and for the mono-ubiquitination of the
FANCI and FANCD2molecular targets (Cole et al., 2010; Hodson
et al., 2011, 2014; Machida et al., 2006). Although FANCL is
active in isolation, its catalytic function is greatly stimulated by
the interaction with FANCB and FAAP100 (Huang et al., 2014;
Rajendra et al., 2014). Whether binding of these two factors
causes an activating conformational switch in the FANCL cata-
lytic center, or whether FANCB and FAAP100 play an architec-
tural role important for mono-ubiquitination, is unknown.
Multiple other architectural aspects of themono-ubiquitination
of FANCI and FANCD2 likewise remain poorly understood. First,
crystallographic studies on mouse proteins indicate that theCell Reports 18, 1–13, January 17, 2017 ª 2016 The Authors. 1
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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metric arrangement. However, the mono-ubiquitination sites
map at the dimerization interface within the ID2 complex (Joo
et al., 2011), suggesting that a reconfiguration of this interface
is needed at some point during the mono-ubiquitination reaction
to allow for access of the E3 ligase assembly. Second, whether a
stable ID2 complex is recruited to the DNA damage site prior to
mono-ubiquitination is unclear, although recent cryoelectron mi-
croscopy (cryo-EM) studies on the unmodified human proteins
support this notion (Liang et al., 2016). Remarkably the symmet-
ric hetero-dimer captured by crystallography cannot be recog-
nized in the electron microscopy (EM) structure, suggesting
that the ID2 complex might visit different conformational states
throughout the ubiquitination reaction. Finally, although both
members of the ID2 dimer need to be mono-ubiquitinated for
activation of the ICL repair pathway (Sims et al., 2007; Smogor-
zewska et al., 2007; Timmers et al., 2001), so far, biochemical
reconstitution has mainly focused on the minimal ability of the
BL100 E3 ligase to mono-ubiquitinate FANCD2, with little to
no FANCI mono-ubiquitination observed (Rajendra et al.,2014).
How equivalent mono-ubiquitination of both FANCI and
FANCD2 is achieved and whether any of the ancillary proteins
in the FA core complex are involved in this process remain unre-
solved questions.
To address these issues, we have used EM, combined with
crosslinking and mass spectrometry (XL/MS), to analyze the ar-
chitecture of the BL100 complex and its substrate ID2, either in
isolation or with other components of the FA core complex. We
found that BL100 forms a symmetric dimer of trimers, inviting a
molecular model for the equivalent ubiquitination of the dimeric
ID2 assembly. The CEF component of the FA core complex
binds to the two extremities in the BL100 dimer, probably acting
as a molecular matchmaker that mediates the BL100 and ID2
interaction. We also uncovered an unexpected structural func-
tion for CEF, which stabilizes the dimerization interface of the
ID2 complex. We postulate that this function might have a direct
role in the efficient mono-ubiquitination of the ID2 hetero-dimeric
substrate. Our findings provide key insights into the structural
basis for the mono-ubiquitination of the ID2 complex, the
defining step in the activation of the FA/BRCA ICL repair
pathway.
RESULTS
BL100 Assembles in a 2-Fold Symmetric Dimer
Although the FANCL subunit of the core complex is an active E3
ligase in isolation (Alpi et al., 2008), its mono-ubiquitination func-
tion is stimulated by 6-fold in the presence of FANCB and
FAAP100 (Rajendra et al., 2014). To understand whether the
B100 association provides a structural framework for efficient
mono-ubiquitination, or whether it causes a conformational
change in FANCL that stimulates its activity, we have expressed
and purified human BL100 from insect cells. Several steps of pu-
rification yielded a pure trimeric complex that eluted with a sharp
peak under gel filtration and with an apparent molecular weight
of 440 kDa (Figures 1A and S1). EM imaging confirmed that
our preparation is highly homogeneous and monodisperse (Fig-
ures 1B and 1C). Two-dimensional classification of negative2 Cell Reports 18, 1–13, January 17, 2017stain data revealed an elongated bow-tie structure containing
apparent 2-fold symmetry (Figure 1D). The particle consists of
a compact center and two globular modules, mapping at the
two extremities of the assembly. Cryo-EM analysis yielded clas-
ses that were highly reminiscent of those obtained after negative
stain imaging; however, no significant improvement in resolution
could be detected, hinting at an inherent flexible nature in the
BL100 complex (Figure 1E). To test our hypothesis that BL100
is mobile and can adopt different structural states, we have per-
formed focused classification on the central core of the struc-
ture, followed by classification on the whole particle without
further alignment. This approach revealed that the globular do-
mains at the two poles in the structure move as rigid bodies,
either tilting or stretching, relative to the central module (Fig-
ure S1; Movie S1). Despite this flexibility, the apparent 2-fold
symmetry is maintained in the central core and at the two poles
in the structure. From the data shown so far, it remains unclear
whether BL100 is, indeed, a 2-fold symmetric assembly or,
rather, contains a pseudo-2-fold symmetry axis, similar to ID2
(Figure 1F). To address this issue, we have repeated the two-
dimensional analysis, using a FANCL derivative that contains
maltose-binding protein (MBP) fused to the N terminus (Figures
2A and S2). MBP tags provide an electron-dense feature that
can be averaged in negative stain EM, and they serve as pointers
to localize individual proteins in a macromolecular assembly
(Chen et al., 2008). We reasoned that a bona fide 2-fold symmet-
ric complex should show two (FANCL-fused) MBP densities that
are dyad related. Indeed, as evident from two-dimensional class
averages, B-(MBP)L100 is decorated with two symmetry-related
MBP densities, establishing that the three factors assemble into
a homo-dimer (B:L:100 = 2:2:2 stoichiometry, with an expected
molecular weight of 468 kDa, coherent with our analytical gel
filtration profile) (Figures 2B and 2C). A dimeric nature of the
FA core complex was unexpected and invites a mechanistic
model for the ID2 mono-ubiquitination reaction that is further
detailed in the Discussion section.
FANCB Is the Sole Candidate for the Homo-dimerization
Interface in the FA Core Complex
Previous reports indicate that RING domains can dimerize
(Brzovic et al., 2001; Liew et al., 2010; Lorick et al., 1999; Pru-
neda et al., 2011), and our MBP analysis shows that the RING-
containing FANCL subunit maps in proximity of the dimerization
interface of BL100 (Figures 2B and 2C). To test whether the FA
core complex dimerization requires FANCL, we have expressed
and purified a subunit dropout assembly that only contains
FANCB and FAAP100 for single-particle analysis (Figures 2D
and S3). In the absence of FANCL, the dimerization interface re-
mains intact, while the globular poles in the assembly become
markedly flexible (Figures 2E and S3; Movie S2), revealing a
structural role for FANCL in stabilizing the BL100 assembly (Fig-
ure 2F), in line with previous reports (Alpi et al., 2008). To identify
the dimerization component in the BL100 complex, we have
attempted to purify the isolated FANCB subunit, but we found
that this factor is insoluble when expressed in the absence of
FAAP100 (data not shown). Conversely, the FAAP100 subunit
is soluble and monodisperse in the absence of FANCB, accord-
ing to analytical gel filtration and single-particle EM (Figures 2G
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Figure 1. FANCB-FANCL-FAAP100 under the Electron Microscope
(A) Coomassie-stained SDS-PAGE gel of the purified BL100 complex.
(B and C) Negative-stain (B) and cryo-EM (C) of the purified BL100 complex.
(D and E) Representative negative-stain (D) and cryo-EM (E) two-dimensional class averages. Box size is 458 A˚ 3 458 A˚.
(F) Top: BL100 forms an elongated, apparently 2-fold symmetric particle containing a dimerization core (blue) and two globular poles (red). Bottom: a cartoon
representation of the assembly with overall particle dimensions.
See also Figure S1.
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sional class averages, centered on the flexible globular pole
component, allows us to recognize FAAP100 as the element
mapping at the extremities of the B100 particle. No resemblance
was detected between the isolated FAAP100 and the dimeriza-
tion core in the assembly (Figures 2H and S3). From these
data, we conclude that FANCB and FAAP100 provide a dimeric
scaffold to position FANCL on opposite poles in the protein as-
sembly (Figure 2I). This suggests that efficient substrate ubiqui-tination requires a 2-fold symmetric arrangement in the FA core
complex. Furthermore, our subunit dropout experiments are
incompatible with a homo-dimerization role for either FANCL
or FAAP100, leaving the FANCB subunit as the sole candidate
for the dimerization element of the BL100 complex.
XL/MS Analysis of the BL100 Assembly
Analytical biochemistry combined with single-particle EM
analysis allowed us to propose a model for the molecularCell Reports 18, 1–13, January 17, 2017 3
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Figure 2. Subunit Architecture of the
FANCB-FANCL-FAAP100 Assembly Studied
by Single-Particle Analysis
(A) Silver-stained SDS-PAGE gel of the assembly
containing an MBP N-terminally fused to FANCL.
(B) Comparison betweenwild-type andMBP fused
BL100 (negative-stain two-dimensional classes).
Two MBP density features are marked with an
orange arrowhead. Box size is 458 A˚ 3 458 A˚.
(C) Cartoon representation of the BL100 complex
with MBP in orange.
(D) Coomassie-stained SDS-PAGE gel of the
purified B100 subcomplex.
(E) Negative-stain two-dimensional classes of
B100. Box size is 458 A˚ 3 458 A˚.
(F) Cartoon model of B100. In the absence of
FANCL, the dimerization core remains unper-
turbed. The poles in the particle are more flexible.
(G) Coomassie-stained SDS-PAGE gel of the iso-
lated FAAP100 subunit.
(H) Comparison between FAAP100 two-dimen-
sional classes and two-dimensional classes of
B100, focused on one pole in the particle. Box size
is 458 A˚ 3 458 A˚.
(I) Cartoon of the BL100 architecture derived from
single-particle EM combined with subunit dropout
experiments.
See also Figures S2 and S3.
Please cite this article in press as: Swuec et al., The FA Core Complex Contains a Homo-dimeric Catalytic Module for the Symmetric Mono-ubiquiti-
nation of FANCI-FANCD2, Cell Reports (2016), http://dx.doi.org/10.1016/j.celrep.2016.11.013architecture of a dimeric BL100 assembly. Difference mapping
suggests that FANCB is located at the homo-dimerization inter-
face; however, we failed in our attempts to directly show that the
isolated FANCB can self-associate. Therefore, we turned to XL/
MS analysis, a powerful tool to study the architecture of macro-
molecular assemblies, especially when combined with structural
EM (Bui et al., 2013) (Figure 3A; Table S1). We have used an
amino-reactive bi-functional crosslinker (BS3) to covalently4 Cell Reports 18, 1–13, January 17, 2017bridge between surface-exposed primary
amines that map within a distance range
of 26–30 A˚ between Ca of lysine residues.
Samples were crosslinked and trypsi-
nized, enriched for larger crosslinked
peptides through gel filtration, and
analyzed by nanoLC-MS (nano-liquid
chromatography-mass spectrometry) us-
ing an LTQ Orbitrap Velos. We first vali-
dated the XL/MS data by comparing our
results with the available crystal structure
of the human FANCL central domain. All
detected crosslinks in FANCL exist within
solvent-exposed lysines that are spaced
within a range compatible with the di-
mensions of the crosslinker spacing arm
(Figure 3B). This control provided us
with confidence in the interaction network
built for the rest of the protein assembly.
Remarkably, FANCB contains, by far,
the highest frequency of intra-molecular
crosslinks, followed by FANCL (Figures
3A and 3C). Only one FAAP100 intra-mo-lecular crosslink was observed. Possible explanations for this
deficiency include the unusually low number of lysines in this
subunit (1.9% of the sequence, with 5.7% being the average in
human proteins), their location in large peptides lacking
trypsin-cleavage sites, or the absence of proximal lysines in
the tertiary structure of FAAP100. Instead, the majority of cross-
linked lysines observed for FAAP100 were involved in inter-mo-
lecular crosslinks with FANCB. Altogether, these data provide
A B
C
Figure 3. Subunit Architecture of the FANCB-FANCL-FAAP100 Assembly Studied by XL/MS
(A) Inter-subunit crosslinks between the six-protein BL100 complex. The lengths of the subunits correspond to the lengths of the colored rectangles that they
represent: blue, FANCB; green, FAAP100; orange, FANCL. Red lines represent intra-molecular crosslinks. Blue lines represent inter-molecular crosslinks.
(B) Crystal structure of the human FANCL central domain with detected lysine residues highlighted in red (PDB: 3ZQS). All detected crosslinks in the FANCL
region covered by the crystal structure map involve lysines that are surface exposed and are spaced within a range compatible with the spacer arm in the BS3
crosslinking agent.
(C) Cartoon representation integrating the crosslinking/mass spectrometry and single-particle analysis characterization of the BL100 architecture. The total
number of detected inter-\intra-molecular crosslinks is indicated for each cartoon.
See also Table S1.
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dimerization interface in the core complex (Figures 2 and 3C).We
note that one of the intra-FANCB crosslinks detected involves
surface-exposed lysines (in position 35 and 39), which flank a
known FA-associated mutation (L37S). Given the immediate
proximity of Lys35 and Lys39, Leu37 is likely solvent exposed
and could serve a role in interacting with other FA proteins.
Further confidence in our XL/MS results is derived from the
striking match between the inter-molecular crosslinks and our
biochemical/EM analysis of the BL100 assembly. For example,
four crosslinks connect FAAP100 with FANCB, in accord with
our finding that FANCB-FAAP100 can exist as an isolated as-
sembly (Figures 3A and 3C). FANCL and FANCB are connected
by five crosslinks, which agrees with the observation that the
MBP N-terminally fused to FANCL maps in close proximity to
the central FANCB homo-dimer (Figure 2B). Conversely, FANCL
and FAAP100 are not crosslinked, in agreement with our findings
that (1) co-expression of FANCL and FAAP100 does not yield aL100 hetero-dimer (data not shown) and that (2) the two subunits
only appear loosely associated in the globular pole in the BL100
particle (Figure 2I). In conclusion, XL/MS analysis, combined
with our single-particle EM, provides a compelling architectural
description of the dimeric BL100 catalytic assembly of the FA
core complex.
Two Copies of CEF Can Associate with the BL100 Dimer
Wehave, so far, established that the BL100 catalytic assembly of
the FA core complex forms a homo-dimer. Whether this arrange-
ment extends to the rest of the core complex, or whether the full
assembly contains a symmetrymismatch element, remains to be
established. Therefore, we decided to purify the CEF assembly
and image it in isolation (as an MBP-FANCC fusion derivative
to increase the overall molecular mass of the complex) (Figures
4A and S4). (MBP)CEF appears as an electron-dense, tri-lobed
entity with no detectable 2-fold symmetry component (Figures
4B and S4). We have then reconstituted a BL100-(MBP)CEFCell Reports 18, 1–13, January 17, 2017 5
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Figure 4. The FANCC-FANCE-FANCF Complex and Its Interaction with FANCB-FANCL-FAAP100
(A) Coomassie-stained SDS-PAGE gel of the CEF complex, containing an MBP N-terminally fused to FANCC.
(B) Negative-stain two-dimensional classes of the of the MBP-CEF complex. Box size is 441 A˚ 3 441 A˚.
(C) Coomassie-stained SDS-PAGE gel of the reconstituted and purified MBP-CEF/BL100 assembly.
(D) Negative-stain two-dimensional classes of the reconstituted and purified (MBP)CEF-BL100 complex. Purple arrowheads point at the MBP-CEF density. Due
to the flexible nature of the BL100-(MBP)CEF interaction, the MBP-CEF complex appears slightly smaller when BL100 is incorporated. A view of the isolated
BL100 is shown, framed in white, for comparison. Box size is 580 A˚ 3 580 A˚.
(E) Cartoon representation of the BL100-CEF architecture.
See also Figure S4.
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tain the characteristic dimeric architecture of BL100 and are
decorated with either one or two CEF additional densities, con-
nected to the globular poles in the bow-tie structure (Figures 4D
and S4). Therefore, binding of two copies of CEF to the BL100
complex is physically possible, indicating that the BL100 dimer
acts as an organizing center for other core complex compo-
nents. Whether two copies of AG20 are found in the full FA
core complex remains to be established and will be the focus
of future studies.
CEF-Co-expressed ID2 Particles Are Compact and
Symmetric
In the BL100-CEF complex, CEF projects outward from the
BL100 dimerization center and appears perfectly poised to latch
onto the outer perimeter of the ID2 mono-ubiquitination sub-
strate (Figure 4D). A direct contact between FANCE and
FANCD2 has been previously reported (Gordon et al., 2005;
Pace et al., 2002; Polito et al., 2014), and in an accompanying
study, we show that human CEF can bind both FANCI and
FANCD2 directly (van Twest et al., 2017). Reconstituting a
CEF-ID2 assembly could, therefore, provide key insights into
the mechanism of the FANCI-FANCD2 mono-ubiquitination by
the FA core complex.
Xenopus laevis ID2 can be expressed and purified to homoge-
neity and efficiently processed in the mono-ubiquitination reac-
tion by the human FA core complex (van Twest et al., 2017).
To gain mechanistic insights into ID2 mono-ubiquitination by
the human FA core complex, we chose to produce Xenopus
ID2 for single-particle EM studies (Figure S5). In agreement
with recently published work (Liang et al., 2016), we observed
that ID2 forms an asymmetric, flexible, dimeric complex, which
resists averaging and high-resolution structure determination6 Cell Reports 18, 1–13, January 17, 2017(Figure S5). We hypothesized that CEF binding might stabilize
the ID2 assembly, and we co-expressed the five proteins in the
attempt to purify an ID2-CEF complex by affinity purification
via a FLAG-tagged FANCI subunit. This purification strategy,
including stringent ion exchange and size exclusion chromatog-
raphy (SEC) steps, yielded an apparently stoichiometric ID2 as-
sembly, according to Coomassie-stained SDS-PAGE gel anal-
ysis, but only trace amounts of the CEF assembly (Figure S6).
As expected from inspection of the SDS-PAGE gel, the vast ma-
jority of ID2 particles show no sign of CEF co-complex, and no
clear evidence for CEF association was detected by inspection
of the two-dimensional classes. To our surprise, however, ID2
particles from the CEF co-expression experiments yielded neatly
averaging two-dimensional classes (Figure S6). A pseudo-2-fold
symmetric end-on view can be recognized in the assembly and
perfectly matches the two-dimensional projections of an elec-
tron density map generated from the PDB coordinates of the
mouse ID2 crystal structure (PDB: 3S4W) (Joo et al., 2011) (Fig-
ure 6A). To confirm this unexpected result, we repeated the co-
expression experiment using a different CEF derivative, contain-
ing a Strep II tag on FANCC (Figure 5A). Single-particle analysis
on the reconstituted complex confirms our initial observations
(Figures 5B–5D and S6). To obtain a three-dimensional structure
of the stabilized ID2 assembly, we generated an initial model
using EMAN2, followed by three-dimensional classification,
and auto-refined the most populated three-dimensional class
to 18.3 A˚ resolution using RELION (Figure 6B; Figure S7).
Rigid-body docking of the mouse atomic structure into the Xen-
opus ID2 map results in an excellent fit, with a striking match at
the hetero-dimerization interface (Figure 6B). Conversely, minor
adjustments would be needed in the C-terminal region of the two
protomers to perfectly fit the atomic structure into the EMdensity
(although we chose not to perform these local adjustments,
A B D
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Figure 5. CEF Co-expression Stabilizes the
FANCI-FANCD2 Interface
(A) Coomassie-stained SDS-PAGE gel of the ID2
complex, with trace amounts of CEF complex.
(B) Representative negative-stain micrograph of the
ID2 assembly. Scale bar, 100 nm.
(C) Two-dimensional class averages of the CEF-sta-
bilized ID2 assembly. Box size is 441 A˚ 3 441 A˚.
(D) CEF has a structural role in reshaping the ID2
interface, summarized in a cartoon.
See also Figures S5 and S6.
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Coherent with a more flexible nature of the FANCI and FANCD2
carboxy-terminal modules, analysis of complex dynamics based
on two-dimensional class averages of end-on views indicates
that the peripheral lobes in the ID2 dimer are flexible (Movie S3).
In summary, our characterization of the ID2-CEF interaction
reveals that the two protein assemblies do not form a stoichio-
metric complex, at least in the experimental conditions tested.
Remarkably, however, CEF co-expression alters the configura-
tion of the ID2 dimer, stabilizing the dimerization interface and
locking the assembly in a pseudo-2-fold symmetric structure
(Figure 5D). This unexpected observation has key implications
for the mechanism of ID2 mono-ubiquitination and suggests a
role for the CEF assembly of the FA core complex.
DISCUSSION
Because the two strands of DNA are antiparallel (Watson and
Crick, 1953), the factors that spatially organize, cut, or open
the double helix are often arranged as symmetric dimers. For
example, a dyad element can be found in the protein core of
the nucleosome (the building block of chromatin in eukaryotic
cells) (Richmond et al., 1984), in DNA integrases (which concert-
edly cut the two DNA strands to insert foreign DNA) (Engelman
and Cherepanov, 2014), or in DNA helicases that unwind the
double helix (Li et al., 2015). This 2-fold symmetric architecture
can then be propagated to a subsequent set of proteins thatphysically interact with the DNA-binding
dimer. A paradigm for this concept is found
in the eukaryotic origin of DNA replication,
where two replisomes are built symmetrically
around a dimer of ring-shaped helicases
(Araki, 2016; Costa et al., 2014; Deegan
et al., 2016) by a set of regulatory and chap-
erone proteins that are, in turn, symmetric di-
mers (Itou et al., 2015).
In our study, we report one additional
example of how a 2-fold symmetric enzyme
modifies a dimeric DNA interactor. In this
case, a homo-dimeric regulator protein acts
symmetrically on a hetero-dimeric assembly.
In the FA/BRCA ICL repair pathway, the
FANCI-FANCD2 dimer binds the double helix
at thedamaged site andacts as a landingplat-
form that recruits a set of DNA-repair proteinsfor ICL processing (Ceccaldi et al., 2016). FANCI and FANCD2 are
structural homologs that can arrange in a pseudo-2-fold-symmet-
ric assembly (Joo et al., 2011). Recruitment of the DNA-repair ma-
chinery requires mono-ubiquitination of both factors (Smogor-
zewska et al., 2007). This function is provided by the FA core
complex,anenzymeassemblywhosearchitecturewaspreviously
unknown (Ceccaldi et al., 2016; Walden and Deans, 2014). Here,
we showed that the trimeric center of the FA core complex
(BL100) exists as a symmetric homo-dimer (Figure 2C). FANCB
and FAAP100 play an architectural role, orienting the two E3 li-
gases in an ideal position to symmetrically target the FANCI and
FANCD2ubiquitinationsites (Figure2I). Inparticular, FANCBplays
a key structural function, being the dimerization factor. We note
that FANCB is the only protomer in the BL100 catalytic module
that contains disease-associated missense mutations, empha-
sizing the key role of this factor in the assembly of a functional
FA core complex (Chandrasekharappa et al., 2013) (http://
databases.lovd.nl/shared/variants/FANCB/unique?search_var_
status=%3D%22Marked%22j%3D%22Public%22). Inspection
ofEMtwo-dimensional classaverages reveals that theBL100par-
ticle is dynamic, with the two catalytic poles of the complex free
to tilt and stretch with respect to the fixed FANCB dimerization
center (Figure S1; Movie S1). Remarkably, this movement occurs
symmetrically across the particle (when the upper lobe moves
to the left, the lower lobe moves to the right, and vice versa). If
the catalytic subunit FANCL is omitted, however, the two external
lobes in the particlemove independently of each other (Figure S3;Cell Reports 18, 1–13, January 17, 2017 7
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Figure 6. Three-Dimensional Reconstruc-
tion of the CEF-Co-expressed FANCI-
FANCD2 Assembly
(A) Representative two-dimensional classes of
the CEF-co-expressed ID2 complex matched to
the two-dimensional projections of the electron
density map generated from the ID2 crystallo-
graphic atomic coordinates (PDB: 3S4W). Box size
is 350 A˚ 3 350 A˚.
(B) Three orientations and a cut-through view of the
X. laevis ID2 EM structure with docked mouse ID2
crystal structure. The fit is excellent, in particular,
at the dimerization interface. Lysines targeted for
mono-ubiquitination are highlighted in red (residue
numbering refers to the mouse proteins, and the
corresponding lysines in the X. laevis ortholog are
indicated in parentheses).
See also Figure S7.
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movement is unclear, it is evident that each of the two catalytic
subunits in the assembly must be able to sense the state of the
symmetry mate in the assembly, and this allosteric communica-
tionmust bemediated by the FANCBdimerization center. In sum-
mary, our study provides the first insights into the mechanics of
this dimeric E3 ligase super-assembly and starts to explain how
the FANCL mono-ubiquitination activity can be stimulated by8 Cell Reports 18, 1–13, January 17, 2017the FANCB and FAAP100 architectural
factors (Rajendra et al., 2014).
The BL100 assembly also functions as
the organizing center of the FA core com-
plex, providing a dimerization scaffold for
the recruitment of a set of two CEF
trimeric assemblies (Figures 4D and S4).
The FANCE subunit of CEF has been pre-
viously reported to interact with the ID2
assembly (Gordon et al., 2005; Pace
et al., 2002; Polito et al., 2014), and our
structural data suggest that CEF might
act as a molecular matchmaker to bridge
between the ID2 mono-ubiquitination
substrate and the BL100 E3 ligase ma-
chinery. Previous structural studies sug-
gest that the ID2 dimer might exist in
different configurations during the ubiqui-
tination reaction. For example, crystalliza-
tion of the murine complex captured
a symmetric, compact state of the ID2
assembly, with the ubiquitination sites
mapping at the dimerization interface,
probably impairing access to the ubiquiti-
nation machinery (Joo et al., 2011).
Conversely, a cryo-EM study of the hu-
man ID2 shows that the complex is more
flexible (poorly averaged) in solution
(Liang et al., 2016). In agreement with
these recent findings, we show that the
intact Xenopus ID2 complex expressedin isolation cannot be captured in discrete conformational states
(two-dimensional images do not average) (Figure S5). In
contrast, the co-expression of CEF with ID2 appears to stabilize
a symmetric state of ID2, which is highly reminiscent of the form
captured in the crystal structure (Figures 5C and 6; Movie S3).
This hints at a possible role for CEF in manipulating the ID2
substrate to facilitate symmetric mono-ubiquitination of the
two related protomers (Figure 7). Biochemical analysis of the
Figure 7. Molecular Model for the Mechanism of FANCI-FANCD2 Mono-ubiquitination by the FA Core Complex
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nation of FANCI-FANCD2, Cell Reports (2016), http://dx.doi.org/10.1016/j.celrep.2016.11.013reconstituted ID2 mono-ubiquitination reaction by the FA core
complex supports our suggestion that the CEF assembly acts
as a nexus between the BL100 enzyme and the ID2 substrate
while also reconfiguring the ID2 structure (van Twest et al.,
2017). Whereas the isolated BL100 assembly solely ubiquiti-
nates the FANCD2 subunit, the presence of CEF significantly
stimulates FANCI mono-ubiquitination, necessary for triggering
initiation of the FA/BRCA ICL repair pathway. How BL100-CEF
and ID2 interact and influence one another remains to be ex-
plained at a molecular level. We note that a disease-associated
mutation on FANCE (R371W), predicted to destabilize the
FANCE fold, abrogates the interaction with FANCD2 in a yeast
two-hybrid study. The same Arg-to-Trp point mutation on
FANCD2 (R302W), mapping within the outer perimeter of the
N-terminal ID2 dimerization module, likewise abrogates the
FANCE-D2 interaction (Joo et al., 2011; Nookala et al., 2007;
Timmers et al., 2001). Such elements likely play an important
role in the CEF-mediated stabilization of the ID2 substrate during
the mono-ubiquitination reaction catalyzed by the homo-dimeric
BL100 catalytic module. Notably, in addition to interacting with
FANCE, the same R302 element in FANCD2 has been previously
implicated in mediating a histone H3 contact (Sato et al., 2012).
How the ID2 mono-ubiquitination reaction occurs in the context
of chromatinized DNA is an exciting frontier topic.
Conclusions
Several outstanding questions will need to be addressed to
understand the mechanism of activation of the FA/BRCA ICL
repair pathway. For example: how do disease mutations affect
the structure and function of the FA core complex? What is the
molecular mechanism for the formation of the FA core complex
in cells? How does DNA influence ID2 mono-ubiquitination?
Our discovery that the FA core complex is a symmetric dimer
changes the way we think about these problems.
EXPERIMENTAL PROCEDURES
Construction of Baculoviruses
Baculoviruses were constructed as detailed in the Supplemental Information.
Protein Expression and Purification
For the expression of the FANCB-FANCL-FAAP100 complex and the isolated
FAAP100, 1 L of Sf9 cells at a titer of 2.0 3 106 cells per milliliter were sus-
pended in 4 L spinner flasks (Corning) and infected with baculovirus at anMOI of 2 for 72 hr at 27C. Cells were collected post-infection by centrifugation
(5,000 rpm, 4C, 15 min), washed in PBS buffer supplemented with 5 mM
MgCl2, and resuspended in lysis buffer (25 mM HEPES NaOH [pH 7.6],
15 mM NaCl, 0.02% Tween 20, 10% glycerol, 1 mM EDTA, 1 mM EGTA,
2mMMgCl2, 2mM2-BME, 0.4mMPMSF, andRoche protease inhibitor cock-
tail). The suspension was lysed by Dounce homogenization (40 strokes, tight
pestle), and NaCl was added to a final concentration of 250 mM. The lysate
was cleared by centrifugation (15000 rpm, 4C, 35 min), and the supernatant
was incubated (3 hr, 4C) with anti-FLAG M2 affinity resin (Sigma Aldrich)
pre-equilibrated with FLAG washing buffer (25 mM HEPES NaOH [pH 8.0],
200 mM NaCl, 0.02% Tween 20, 10% glycerol, 1 mM EDTA, 1 mM EGTA,
and Roche protease inhibitor cocktail). After wash, the sample was eluted
with FLAG elution buffer (25 mM HEPES NaOH [pH 8.0], 100 mM NaCl,
0.02% Tween 20, 5% glycerol, 1 mM EDTA, 1 mM EGTA, 0.3 mg/mL FLAG
peptide, and Roche protease inhibitor cocktail). Elution fractions were com-
bined and loaded onto a Mono Q 5/50 GL for ion-exchange chromatography
(GE Healthcare). The column was washed with Q-Wash buffer (25 mM HEPES
NaOH [pH 8.0], 150 mM NaCl, 5% glycerol, 1 mM EDTA, 1 mM EGTA, 0.5 mM
TCEP, and Roche protease inhibitor cocktail) and eluted over a 150-mM to
650-mM NaCl linear gradient in the same buffer. The peak fraction from
cation-exchange chromatography was loaded onto a Superose 6 PC 3.2/30
column (GE Healthcare) operating on an A¨KTAmicro HPLC (high-performance
liquid chromatography) system (GEHealthcare) andwas equilibrated in 25mM
HEPES NaOH (pH 8.0), 250 mM NaCl, and 1 mM TCEP. The proteins were
separated by SDS-PAGE, using 4%–12% Bis-Tris gels (Invitrogen) running
for 50 min at 150 V in MOPS buffer or using 3%–8% Tris-acetate gels (Invitro-
gen) running for 60 min at 150 V in Tris-acetate buffer. Protein identities were
confirmed by MS. Protein concentration was determined by measuring absor-
bance at 280 nm (A280nm) using a NanoDrop ND-1000 spectrophotometer
(NanoDrop Technologies).
Expression of the FANCB-FAAP100 and FANCB-(MBP)FANCL-FAAP100
complexes were performed using the FANCB-FANCL-FAAP100 protocol;
however, infection was performed using an MOI of 1 for 72 hr at 27C. Pro-
tein extraction, purification, and identification were performed as described
earlier. Freshly purified samples (BL100 at 1 mg/mL, B100 at 0.25 mg/mL,
and FAAP100 at 1.5 mg/mL) were immediately used for negative-stain EM
or cryo-EM experiments.
Expression and purification of (MBP)FANCC-FANCE-FANCF was per-
formed as follows. 1 L of Sf9 cells at a titer of 1.0 3 106 cells per milliliter
was suspended in 4-L spinner flasks (Corning) and infected with baculovirus
at an MOI of 1 for 72 hr at 27C. Cells were collected post-infection by
centrifugation (5,000 rpm, 4C, 15 min), washed in PBS buffer supplemented
with 5 mM MgCl2, and resuspended in lysis buffer (25 mM HEPES NaOH
[pH 7.6], 15 mM NaCl, 0.02% Tween 20, 10% glycerol, 1 mM EDTA, 1 mM
EGTA, 2 mM MgCl2, 15 mM 2-BME, 0.6 mM PMSF, and Roche protease
inhibitor cocktail). The suspension was lysed by Dounce homogenization
(40 strokes, tight pestle), and NaCl was added to a final concentration
of 200 mM. The lysate was cleared by centrifugation (15,000 rpm, 4C,
35 min), and the supernatant was incubated (2 hr, 4C) with Amylose resin
(New England Biolabs) pre-equilibrated with Amylose wash buffer (25 mMCell Reports 18, 1–13, January 17, 2017 9
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EDTA, 1 mM EGTA, 0.25 mM TCEP, and Roche protease inhibitor cocktail).
After extensive wash, the sample was eluted by ligand competition using the
Amylose wash buffer supplemented with 20 mM maltose (Sigma). Peak frac-
tions were pooled and loaded onto a Mono Q 5/50 GL for ion-exchange chro-
matography (GE Healthcare). The column was washed with buffer Q-A (50mM
HEPES NaOH [pH 8.0], 150 mM NaCl, 5% glycerol, 1 mM EDTA, and 0.5 mM
TCEP) and eluted over a linear salt gradient with buffer Q-B (50 mM HEPES
NaOH [pH 8.0], 1 M NaCl, 5% glycerol, 1 mM EDTA, and 0.5 mM TCEP).
Peak fraction was successively loaded onto a Superose 6 PC 3.2/30 column
(GE Healthcare) operating on an A¨KTAmicro HPLC system (GE Healthcare)
and separated by SEC in 25 mM HEPES NaOH (pH 8.0), 100 mM NaCl, and
2 mM DTT. Peak fraction was analyzed by SDS-PAGE. Instant Blue Safe-
Stain-stained (Expedeon) bands were identified by MS. Sample concentration
was measured by A280nm using a NanoDrop ND-1000 spectrophotometer
(NanoDrop Technologies) and the (MBP)CEF theoretical extinction coefficient.
Freshly purified (MBP)CEF sample at a final concentration of 0.5 mg/mL was
immediately used for preparation of negative-stain EM grids or reconstitution
with freshly purified BL100 sample.
Expression and purification of the FANCI-FANCD2 complex was performed
as follows. Briefly, 1 L of Sf9 cells at a titer of 2.0 3 106 cells per milliliter was
suspended in 4-L spinner flasks (Corning) and co-infected with the two bacu-
loviruses, each at MOI of 1, for 72 hr at 27C. Following the co-infection, cells
were collected by centrifugation (5,000 rpm, 4C, 15 min) and washed in PBS
buffer supplemented with 5 mMMgCl2. Cells were resuspended in lysis buffer
(25 mM HEPES NaOH [pH 7.6], 15 mM NaCl, 0.02% Tween 20, 10% glycerol,
1 mM EDTA, 1 mM EGTA, 2 mM MgCl2, 2 mM 2-BME, 0.4 mM PMSF, and
Roche protease inhibitor cocktail) and lysed by Dounce homogenization
(40 strokes, tight pestle). To preserve complex integrity, the lysate was added
with NaCl to a final concentration of 150 mM and cleared by centrifugation
(15,000 rpm, 4C, 35 min). The supernatant was collected and incubated
(3 hr, 4C) with anti-FLAG M2 affinity resin (Sigma-Aldrich) pre-equilibrated in
FLAG washing buffer (25 mM HEPES NaOH [pH 8.0], 120 mM NaCl, 0.02%
Tween 20, 10% glycerol, 1 mM EDTA, 1 mMEGTA, and Roche protease inhib-
itor cocktail). After extensivewash, theproteinswereelutedby incubationof the
resin in FLAGelution buffer (25mMHEPESNaOH [pH8.0], 120mMNaCl, 1mM
EDTA, 0.3 mg/mL FLAG peptide, and Roche protease inhibitor cocktail). Peak
fractions were combined and loaded onto a Mono Q 5/50 GL(GE Healthcare)
column running in buffer Q-A (25 mM HEPES NaOH [pH 8.0], 100 mM NaCl,
5% glycerol, 1 mM EDTA, and 0.25 mM TCEP). Elution of the sample was per-
formedover a linear salt gradientwith bufferQ-B (25mMHEPESNaOHpH8.0],
750 mM NaCl, 5% glycerol, 1 mM EDTA, and 0.5 mM TCEP). To increase
sample homogeneity, the complex was further purified by pull-down of the
Strep-tag II on FANCD2. Peak fraction from ion-exchange chromatography
was incubated for 2 hr at 4Cwith Strep-tactin Superflow plus resin (QIAGEN).
The resin was washed in Strep-wash buffer (25 mM HEPES NaOH [pH 8.0],
120 mM NaCl, 10% glycerol, 1 mM EDTA and 0.25 mM TCEP) and eluted by
incubation with Strep-wash buffer supplemented with 25 mM desthiobiotin.
Fractions containing stoichiometric I-D2 complex were pooled and concen-
trated on Amicon Ultra MWCO 10K centrifugal filters (Millipore). Concentrated
sample was separated by size exclusion on a Superdex 200 PC 3.2/30 column
(GE Healthcare) operating on an A¨KTAmicro HPLC system (GE Healthcare)
running in 25 mM HEPES NaOH (pH 8.0), 120 mM NaCl, and 1 mM TCEP.
Elution peak was analyzed by SDS-PAGE followed by Instant Blue SafeStain
staining (Expedeon). Band identity was confirmed by MS. Freshly purified ID2
sample at a final concentration of 0.25 mg/mL was immediately used for prep-
aration of negative-stain EM grids.
Co-expression of FANCI-FANCD2-FANCC-FANCE-FANCF was obtained
by infecting Sf9 cells with baculoviruses encoding for FANCI, FANCD2, and
either MBP-tagged or StrepII-tagged CEF. Briefly, 1 L Sf9 cells at a titer of
2.0 3 106 cells per milliliter were co-infected with baculoviruses encoding
for FLAG-FANCI, StrepII-FANCD2, and (MBP)CEF (or (StrepII)CEF), each at
a MOI of 1. Cells were incubated for 72 hr at 27C. Protein extraction, purifica-
tion, and identification were carried out as previously described for the ID2
complex. The ID2-(StrepII)CEF sample purified from ion-exchange chroma-
tography and the ID2-(MBP)CEF sample purified from SEC were used for
preparation of EM grids by negative stain immediately after purification.10 Cell Reports 18, 1–13, January 17, 2017Reconstitution of the BL100-(MBP)CEF Complex
The reconstitution of the FANCB-FANCL-FAAP100-(MBP)FANCC-FANCE-
FANCF complex was performed by mixing equal volumes of a freshly purified
1-mMsolution of BL100 and a 3-mMsolution of CEF (resulting in amolar ratio of
1:3) and loaded on a 30K MWCO Slide-a-Lyzer dialysis cassette (Thermo Sci-
entific). The protein mix was first dialyzed for 1 hr at 4C in Buffer 500 (25 mM
Tris-HCl [pH 8.0], 500 mM NaCl, 5% glycerol, and 1 mM DTT), then for 2 hr in
Buffer 350 (25 mM Tris-HCl [pH 8.0], 350 mM NaCl, 5% glycerol, and 1 mM
DTT), and finally overnight in Buffer 100 (25 mM Tris-HCl [pH 8.0], 100 mM
NaCl, 5% glycerol, and 1 mM DTT). The sample was recovered from the dial-
ysis cassette and loaded onto a Superose 6 PC 3.2/30 column (GE Healthcare)
operating on a A¨KTAmicro FPLC (fast protein liquid chromatography) system
(GE Healthcare) equilibrated in 25 mM Tris-HCl (pH 8.0), 100 mM NaCl, and
2 mM DTT. In control experiments, isolated dialyzed BL100 and (MBP)CEF
complexes were also subject to SEC as described for the reconstituted sam-
ples. Samples were analyzed by SDS-PAGE on 3%–8% Criterion XT Tris-
Acetate gels (Bio-Rad) followed by Instant Blue SafeStain staining (Expedeon).
Freshly purified samples were immediately used for the preparation of EM
grids.
Negative-Stain EM Sample Preparation
A 2- to 6-nm-thick carbon layer was evaporated onto freshly cleaved mica
sheets (EMS) using a Q150TE carbon coater (Quorum Technologies). Carbon
was incubated overnight at 50C before floating on 600-mesh copper grids
(Agar Scientific) or Quantifoil R1.2/1.3 300-mesh copper grids. Prior to sample
incubation, the carbon-coated grid was glow discharged for 30 s at 45 mA us-
ing a 1003 glow discharger (EMS). Serial dilutions of each protein sample were
performed to achieve optimal particle concentration on the EM grid (final con-
centrations ranged from 30 to 5 mg/mL). A 4-mL drop of the freshly purified
sample solution was applied onto the glow-discharged grid and incubated
for 1 min. Approximately 2 mL of sample solution was absorbed by gentle
side blotting, and the grid was immediately stained with four subsequent ap-
plications onto 43 50-mL drops of a 2% (wt/vol) uranyl formate solution with
gentle stirring for 8 s. After staining, the grid was blotted dry and stored at
room temperature prior to imaging.
Negative-Stain EM Data Collection
Particles of reconstituted BL100-(MBP)CEF, isolated (MBP)CEF, isolated ID2,
and ID2 co-expressed with (MBP)CEF were imaged on a Tecnai G2 Spirit LaB6
transmission electron microscope (TEM; FEI) operating at 120 keV (Electron
Microscopy Science Technology Platform, The Francis Crick Institute). Images
were manually acquired on a UltraScan 1000 2k 3 2k charge-coupled device
(CCD) camera (Gatan) at a nominal magnification of 30,0003 (corresponding to
a pixel size of 3.45 A˚ at the specimen level). Particles of BL100, B100, B-(MBP)
L100, isolated FAAP100, and ID2 co-expressed with (StrepII)CEF samples
were imaged using a JEM-2100 LaB6 electron microscope (JEOL) operated at
120 kV. Images were recorded on a UltraScan 4k 3 4k CCD camera (Gatan)
at a nominal magnification of 42,0003 corresponding to a pixel size of 2.73 A˚
at the specimen level. On both microscopes, images were collected in low-
dose mode (electron dose of 35 e/A˚2) and with defocus values in the range of
0.5 mm to 2.0 mm. For the BL100 and FAAP100 samples, the micrographs were
automatically recorded using the JEOL Automated Data Acquisition System
(JADAS) with same electron dose and defocus value as the manual collection.
A total of 567 images were collected for the BL100 sample, 250 images for the
B100 sample, 412 images for the B-(MBP)L100 sample, 540 images for the
FAAP100 sample, 277 images for the (MBP)CEF sample, 455 images for
the BL100-(MBP)CEF sample,712 images for the ID2 sample, 468 images for
the ID2-(MBP)CEF sample, and 447 images for the ID2-(StrepII)CEF sample.
Cryo-EM Sample Preparation and Data Collection
Ultrathin carbon-coated Lacey 300-mesh copper grids (Ted Pella) were glow
discharged for 30 s at 45 mA using a 1003 glow discharger (EMS) and
mounted onto a Vitrobot Mark IV (FEI). A 4-mL drop of freshly purified BL100
at a concentration of 20 mg/mL was applied to the glow-discharged grid.
The sample was incubated on the grid for 1min in 100%humidity at 21C. After
incubation, the grid was double-side blotted for 2.0 s and rapidly plunged in
liquid ethane. Cryo-EM data for the BL100 sample were collected on a Titan
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II (FEI) direct electron detector at a nominal magnification of 47,0003 , result-
ing in a pixel size of 1.77 A˚ at the specimen level. A total of 2,798 images were
recorded at defocus values in the range of 2.5–4.5 mm and with a cumulative
electron dose of 56 e/A˚2 distributed over 26 frames. Beam-induced motion
was corrected on each image using the Motioncorr program (Li et al., 2013).
Micrographs showing contamination drift, or out-of-range defocus values
were discarded.
Single-Particle Image Processing
For each dataset, particles were semi-automatically picked using the EMAN2
package, version 2.12 (Tang et al., 2007). From the negative-stain EM data
collection, a total of 63,543 individual particles were extracted from the
BL100 dataset, 63,365 particles from the B100 dataset, 51,941 particles
from the B-(MBP)L100 dataset, 177,106 particles from the FAAP100 dataset,
36,768 particles from BL100-(MBP)CEF dataset, 47,898 particles from the
(MBP)CEF dataset, 95,553 particles from the ID2 dataset, 27,084 particles
from the ID2-(MBP)CEF dataset, and 71,295 particles from the ID2-(StrepII)
CEF dataset. From the BL100 cryo-EM dataset, a total of 536,754 individual
particles were extracted from selected micrographs. The parameters of the
contrast transfer function (CTF) were estimated on each micrograph using
CTFFIND3 (Mindell andGrigorieff, 2003) for negative-stain data andCTFFIND4
(Rohou and Grigorieff, 2015) for cryo-EM data. Reference-free two-dimen-
sional alignment and averaging was performed using RELION, version 1.4
(Scheres, 2012). For three-dimensional reconstruction of the ID2 complex
co-expressed with (StrepII)CEF, an initial three-dimensional volume was
generated using the e2inimodel.py program in the EMAN2 package (Tang
et al., 2007). The initial volumewas used as a reference model for three-dimen-
sional classification and refinement in RELION 1.4 (Scheres, 2012). The atomic
model of the FANCI-FANCD2 hetero-dimer (PDB: 3S4W) (Joo et al., 2011) was
used for rigid-body fitting into the EMmap using UCSF (University of California,
San Francisco) Chimera (Pettersen et al., 2004). The refined EMmap of the ID2
hetero-dimer has been deposited in the three-dimensional-EM database
(http://www.emdatabank.org) with accession number: EMD-3476.
XL/MS
All chemicals were purchased from Sigma at the highest grade possible, un-
less otherwise stated. BS3 d0 and BS3 d4were purchased from ThermoFisher
Scientific. nano-LC-MS solvents and additives were purchased as LC-MS
grade from Fisher Scientific. The XL/MS workflow was conducted as previ-
ously described (Leitner et al., 2014). Briefly, BL100 dimer, at a concentration
of 0.5 mg/mL in 25 mM HEPES (pH 8), 300 mM NaCl, 10% glycerol, and
0.25 mM tris(2-carboxyethyl)phosphine (TCEP), was reacted with 5 mM BS3
(using a 50:50 ratio of d0 and d4) for 30 min at 37C. The reaction was
quenched by adding 50 mM ammonium bicarbonate for 20 min at 37C and
then dried to completion using vacuum centrifugation. The sample was resus-
pended at a concentration of 1 mg/mL using 8 M urea, reduced with 2.5 mM
TCEP, and alkylated with 5 mM iodoacetamide. The sample was diluted with
50 mM ammonium bicarbonate to reduce the urea concentration to 1 M,
and trypsin (Promega) was added at a 1:50 enzyme:substrate ratio and left
to digest overnight at 37C. The solution was then acidified, and peptides
were purified using C18 in house solid-phase elution tips (Empore, 3M).
For size exclusion fractionation, the peptides were resuspended in SEC
buffer (70% H2O, 30% acetonitrile, and 0.1% trifluoroacetic acid), and chro-
matographically separated using an A¨KTAmicro (GE Healthcare) with a Super-
dex Peptide PC 3.2/30 column (GE Healthcare) and detected using 215 nm
absorbance. The flow rate was set to 50 mL/min, and 100 mL fractions were
collected and dried to completion using vacuum centrifugation. For nano-
LC-MS acquisition, the SEC fractions were resuspended into 30 mL of 0.1% tri-
fluoroacetic acid in H2O, and 1 mL was injected and chromatographically
resolved using an Ultimate 3000 RSLCnano (Dionex) with an EASY-Spray col-
umn (2-mm particles, PepMap C18, 100-A˚ pore size, 50 cm 3 75 mm ID)
(Thermo Scientific). A flow rate of 0.25 mL/min was used, starting at 98% mo-
bile A (0.1% formic acid, 5%DMSO, 95%H2O) and 2%mobile B (0.1% formic
acid, 5% DMSO, 80% acetonitrile, 10%H2O). Over 80 min, Mobile B was then
increased to 40% followed by a further increase to 90% over 10 min. Spectra
were acquired in real time using an LTQ Orbitrap Velos Mass Spectrometer(Thermo Scientific) with a 400 to 2,000 m/z (mass-to-charge ratio) acquisition
window. The top ten most intense ions with a charge state of +3 or greater
were then selected for tandemMS (MS/MS) using data-dependent acquisition
and CID (collision-induced dissociation) fragmentation (at 35% normalized
collision energy). A dynamic exclusion list, with a repeat count of 1, repeat
duration of 20 s, exclusion list size of 100, and exclusion duration of 30 s,
was used to prevent repeat sampling. Data analysis was carried out using
the xQuest/xProphet (v2.1.1) workflow. The data were searched for BS3
mono-links (+156.079 Da for water quench, +155.096 Da for ammonium
quench), intra-links, and intra- and inter-protein crosslinks (+138.068 Da) on
lysine residues, using isotopic pairing with a mass shift of +4.025 Da for BS3
d4 ions, in addition to a fixed carbamidomethylation modification (+57.021
Da) and variable methionine oxidation (+ 15.994 Da). The data were searched
using a 10-ppm mass tolerance for charge states +3 or above. xProphet was
then used, and peptides with a false discovery rate (FDR) below 5%were then
manually assessed for adequate signal intensity and peak assignment.
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